Table 1.
The main demographic and clinical data of the patients included in the study.
| All (%) | EGF (%) | DGF (%) | p | |
|---|---|---|---|---|
| n. | 932 | 706 (75.7) | 226 (24.3) | |
| Age (years) | 45.8 ± 11.2 | 44.9 ± 11.3 | 48.5 ± 10.7 | <0.0001 |
| Gender (M/F) | 595 (63.8)/337 (36.2) | 444 (62.9)/262 (37.1) | 150 (66.4)/76 (33.6) | 0.4 |
| Dialysis (HD/PD) | 851 (91.3)/81 (8.7) | 631 (89.4)/75 (10.6) | 218 (96.5)/8 (3.5) | 0.005 |
| Dialysis vintage (years) | 6.2 ± 4.4 | 5.8 ± 4.3 | 7.4 ± 4.7 | <0.0001 |
| HCV+ (n,%) | 156, 16.7 | 98, 13.9 | 58, 25.4 | <0.0001 |
| Body mass index (BMI) (kg/m2) | 24.0 ± 3.8 | 23.7 ± 3.8 | 24.9 ± 3.8 | 0.0001 |
| Panel reactive antibodies (%) | 7.5 ± 5.2 | 7.4 ± 4.9 | 7.6 ± 5.7 | 0.8 |
| Cold ischemia time (hours) | 12.7 ± 5.0 | 13.0 ± 5.2 | 12.2 ± 6.5 | 0.4 |
| Mismatches (n) | 3.2 ± 0.9 | 3.1 ± 0.9 | 3.3 ± 0.9 | 0.1 |
| Donor age (years) | 45.1 ± 17.5 | 43.3 ± 17.3 | 50.5 ± 16.7 | <0.0001 |
| Donor serum creatinine (mg/dl) | 1.28 ± 0.75 | 1.23 ± 0.6 | 1.44 ± 1.0 | 0.04 |
| Cause of death (trauma/vascular) | 304 (32.6)/628 (67.4) | 289 (40.9)/417 (59.1) | 75 (33.2)/151 (66.8) | 0.02 |
| Cyclosporine (n) | 408 (43.7) | 307 (43.5) | 101 (44.7) | 0.6 |
| Tacrolimus (n) | 479 (51.4) | 368 (52.1) | 111 (49.1) | 0.8 |
| mTOR inhibitors (n) | 80 (4.9) | 76 (4.4) | 4 (6.2) | <0.0001 |